Category Archives: Europe

À l’Inserm, la lutte contre la pandémie de Covid-19 se poursuit

Pour faire face à la pandémie de Covid-19, mieux comprendre le virus et accompagner la prise en charge des maladies, les scientifiques de l’Inserm sont plus que jamais mobilisés.

Published Now in the New England Journal of Medicine: The Initial Results of the Solidarity/Discovery Clinical Trial

Back at the start of the pandemic, Inserm, through its REACTing consortium, set up Discovery: a European clinical trial to evaluate the efficacy of four antiviral drugs repurposed for the treatment of patients hospitalized with COVID-19 (remdesivir, hydroxychloroquine, lopinavir and interferon beta-1a). In parallel, the World Health Organization (WHO) set up Solidarity, a major consortium of clinical trials also aimed at testing the efficacy of these four treatments. Discovery then joined forces with Solidarity to help supply it with robust and rigorous data.

Early Environmental Exposures and Child Respiratory Health: the Exposome Reveals its Preliminary Results

A team of researchers from Inserm, CNRS, Université Grenoble Alpes and Barcelona Institute for Global Health has shown that prenatal and postnatal exposure to various chemical pollutants is linked to decreased respiratory function in children. These results, based on the concept of the exposome (defined as the totality of an individual’s environmental exposures from conception until old age), were obtained as part of the European HELIX project and have been published in The Lancet Planetary Health.

Photographie de la santé périnatale en France et en Europe en 2015

Le 26 novembre 2018 est publié le nouveau rapport Euro-Peristat, projet européen coordonné par l’Inserm, mis en place depuis 2000, et qui rassemble des statistiques de 31 pays sur la santé périnatale en 2015. La comparaison de la France par rapport à ses voisins conduit à un bilan contrasté, avec en particulier une situation maitrisée dans la pratique des césariennes, mais une situation moins favorable pour la mortalité des enfants et la consommation de tabac, là où de nombreux pays observent une amélioration.

Achievements in Innovation: Inserm Sets Itself Apart Once Again Through its Momentum and Results

The respective classifications of the European Patent Office (EPO) and France’s National Industrial Property Institute (INPI), which have just published their annual rankings for 2017, have confirmed Inserm’s ability to innovate. Inserm placed first among patent applicants in the pharmaceutical sector for the second year in a row, yet again leading the rankings of European applicants in this sector, ahead of both industrial manufacturers and academic institutions. Furthermore, the Institute was in 30th place – having moved up five places – in the INPI’s “patents in all fields” ranking, confirming its research teams’ excellence and productivity in innovation.

Very premature infants: towards better care

Born too soon, very premature infants are particularly vulnerable and need appropriate care. The European project EPICE (Effective Perinatal Intensive Care in Europe) examines how medical practices based on scientific evidence are incorporated into the care of these neonates[1]. The study, coordinated by Inserm and published in The British Medical Journal, highlights the underuse of four effective practices for improving their survival and long-term health, and estimates its impact on mortality and morbidity.

ENS@T-HT, launch of a large scale Europe H2020 project coordinated by Inserm for improved diagnosis and treatment of arterial hypertension through an omics-based approach

Des scientifiques provenant de 6 pays, réunis au sein du projet ENS@T-HT mettent en commun leur expertise afin d’améliorer le diagnostic et la prise en charge thérapeutique de l’hypertension artérielle primaire et secondaire par une approche axée sur les « omiques ». Le projet ENS@T-HT, coordonné par Maria-Christina Zennaro, Directrice de recherche à l’Inserm (Centre de recherche Cardiovasculaire de Paris), a été officiellement lancé ce mois-ci à Paris et durera 5 ans.

Europeans and biomedical research

The French National Institute of Health and Medical Research (Inserm) is currently the leading biomedical research organisation in Europe, and plays a key role in developing European research. To mark its 50th anniversary, Inserm wanted to assess the perceptions of Europeans regarding biomedical research.

Yes, you can make your children eat vegetables!

Researchers have made a step forward in the understanding of how eating behaviours and preferences form in early life.

Europe is joining forces against neglected parasitic diseases

The international consortium A-PARADDISE (Anti-Parasitic Drug Discovery in Epigenetics), coordinated by Inserm, has just obtained funds of €6 million from the European Commission to conduct large-scale testing of innovative therapies against four neglected parasitic diseases: schistosomiasis, leishmaniasis, Chagas disease and malaria.

RSS Youtube